BOSTON — The Molecular Targets meeting, a joint endeavor of the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer (AACR-NCI-EORTC), wrapped up a lively four days on Monday with a discussion of "the in vitro patient."